Hydrocortisone / neomycin / polymyxin B Otic Solution
RxNorm 378643
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 378643 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: hydrocortisone / neomycin / polymyxin B Otic Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDFPrescribable
Semantic Clinical Drug Form (SCDF):
Hydrocortisone / neomycin / polymyxin B Otic Solution
(Atom ID: 12258795)
Patient Education
Neomycin, Polymyxin, and Hydrocortisone Otic
Neomycin, polymyxin, and hydrocortisone otic combination is used to treat outer ear infections caused by certain bacteria. It is also used to treat outer ear infections that can occur after certain types of ear surgery. Neomycin and polymyxin are in a class of medications called antibiotics. They work by stopping the growth of bacteria. Hydrocortisone is in a class of medications called corticosteroids. It works by activating natural substances in the ear to reduce swelling, redness, and itching.
[Learn More]
* Please review the disclaimer below.